Literature DB >> 6490844

Diarrhea due to Plesiomonas shigelloides in cancer patients.

K V Rolston, R L Hopfer.   

Abstract

Plesiomonas shigelloides was isolated from the stools of two patients with gastrointestinal malignancies and from one "healthy" patient with diarrhea. No other enteric pathogens were isolated. One patient was neutropenic after antineoplastic chemotherapy. The two cancer patients had crampy abdominal pain and severe diarrhea and required antibiotic therapy for resolution of symptoms. The third patient responded to symptomatic treatment. Patients with gastrointestinal malignancies may be more susceptible to gastroenteritis caused by P. shigelloides than normal individuals, and these infections may be more severe than those seen in normal individuals.

Entities:  

Mesh:

Year:  1984        PMID: 6490844      PMCID: PMC271384          DOI: 10.1128/jcm.20.3.597-598.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  Aeromonas shigelloides bacteremia: a case report.

Authors:  P D Ellner; L R McCarthy
Journal:  Am J Clin Pathol       Date:  1973-02       Impact factor: 2.493

2.  Acute colitis due to Plesiomonas shigelloides.

Authors:  B K Mandal; K Whale; B C Morson
Journal:  Br Med J (Clin Res Ed)       Date:  1982-11-27

3.  Neonatal septicemia and meningitis due to Aeromonas shigelloides.

Authors:  P C Appelbaum; A J Bowen; M Adhikari; R M Robins-Browne; H J Koornhof
Journal:  J Pediatr       Date:  1978-04       Impact factor: 4.406

4.  Enteropathogenicity of Plesiomonas shigelloides.

Authors:  S C Sanyal; B Saraswathi; P Sharma
Journal:  J Med Microbiol       Date:  1980-08       Impact factor: 2.472

5.  Evaluation of differential and selective media for isolation of Aeromonas and Plesiomonas spp. from human feces.

Authors:  A von Graevenitz; C Bucher
Journal:  J Clin Microbiol       Date:  1983-01       Impact factor: 5.948

6.  Enteropathogenicity of Aeromonas hydrophila and Plesiomonas shigelloides: prevalence among individuals with and without diarrhea in Thailand.

Authors:  C Pitarangsi; P Echeverria; R Whitmire; C Tirapat; S Formal; G J Dammin; M Tingtalapong
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

7.  Plesiomonas (Aeromonas) shigelloides septicemia and meningitis in a neonate.

Authors:  L J Dahm; A G Weinberg
Journal:  South Med J       Date:  1980-03       Impact factor: 0.954

8.  Plesiomonas shigelloides septic arthritis complicating rheumatoid arthritis.

Authors:  D L Gordon; C R Philpot; C McGuire
Journal:  Aust N Z J Med       Date:  1983-06

9.  A survey of Plesiomonas shigelloides from aquatic environments, domestic animals, pets and humans.

Authors:  T Arai; N Ikejima; T Itoh; S Sakai; T Shimada; R Sakazaki
Journal:  J Hyg (Lond)       Date:  1980-04

10.  Snake-to-human transmission of Aeromonas (Pl) shigelloides resulting in gastroenteritis.

Authors:  W A Davis; J H Chretien; V F Garagusi; M A Goldstein
Journal:  South Med J       Date:  1978-04       Impact factor: 0.954

View more
  5 in total

1.  Activity of newer antimicrobial agents against Aeromonas hydrophila.

Authors:  K V Rolston; D H Ho; B LeBlanc; G P Bodey
Journal:  Eur J Clin Microbiol       Date:  1986-08       Impact factor: 3.267

2.  Effect of acidity and antimicrobial agent-like compounds on viability of Plesiomonas shigelloides.

Authors:  J M Janda
Journal:  J Clin Microbiol       Date:  1987-07       Impact factor: 5.948

3.  Laboratory observations on Plesiomonas shigelloides strains isolated from children with diarrhea in Peru.

Authors:  O Olsvik; K Wachsmuth; B Kay; K A Birkness; A Yi; B Sack
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

4.  Septicaemia and pleural effusion due to Plesiomonas shigelloides.

Authors:  H Humphreys; B Keogh; C T Keane
Journal:  Postgrad Med J       Date:  1986-07       Impact factor: 2.401

5.  Prevalence of Plesiomonas shigelloides among diarrhoeal patients in Bangladesh.

Authors:  Z Rahim; A Ali; B A Kay; R Zeaur; A Akbar; A K Bradford
Journal:  Eur J Epidemiol       Date:  1992-09       Impact factor: 8.082

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.